Albany, US – DelveInsight launched its new report on Hot Flashes – Market Insights, Epidemiology and Market Forecast-2030
DelveInsight’s ‘Hot Flashes – Market Insights, Epidemiology and Market Forecast-2030‘ report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Hot Flashes in the United States, EU5 (Germany, Spain, Italy, France and the United Kingdom), and Japan.
Some key facts of the report:
1. The prevalent population of Hot Flashes Associated with post-menopause in the 7MM countries was observed to be 41,942,422 in 2017.
Key benefits of the report:
1. Hot Flashes market report covers a descriptive overview and comprehensive insight of the Hot Flashes epidemiology and Hot Flashes market in the 7 MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. Hot Flashes market report provides insights into current and emerging therapies.
3. Hot Flashes market report provides a global historical and forecasted market covering drug outreach in 7 MM.
4. Hot Flashes market report offers an edge that will help in developing business strategies by understanding trends shaping and leading the Hot Flashes market.
Request for sample pages: https://www.delveinsight.com/sample-request/hot-flashes-market
“The overall mild Hot Flashes prevalence was maximum in the United States, followed by moderate and severe and is subjected to increase rapidly in the coming years.”
Vasomotor Symptoms (VMS) is one of the major symptoms of menopause that principally include hot flashes (HF) and night sweats (NS) during menopause and occurs in the majority of women across the globe. A woman with VMS experiences abundant heat accompanied by sweating and flushing, especially around head, neck, chest, and upper back region.
Key pharma companies involved:
1. TherapeuticsMD
2. Besins Healthcare
3. Mithra Pharmaceuticals
4. Endoceutics
Drugs covered:
1. TX?001HR
2. BHR?401
3. Donesta
4. DHEA and Acolbifene
Request for a free sample report @https://www.delveinsight.com/sample-request/hot-flashes-market
Table of contents:
1. Key Insights
2. Hot Flashes Market Overview at a Glance
3. Hot Flashes associated with menopause Disease Background and Overview
4. Hot Flashes Epidemiology and Patient Population
5. Total Prevalent Patient Population of Hot Flashes Associated with Post-menopause
in the 7MM Countries
6. Hot Flashes Associated with Post-menopause Country Wise-Epidemiology
6.1. United States
6.2. EU5 Countries
6.3. Germany
6.4. France
6.5. Italy
6.6. Spain
6.7. The United Kingdom
6.8. Japan
7. Hot Flashes Treatment Algorithm, Current Treatment, and Medical Practices
8. Unmet Needs
9. Hot Flashes Marketed drugs by class
9.1. Hormonal Therapies
9.2. Non-Hormonal Therapies
10. Hot Flashes Emerging Therapies
10.1. Key Cross Competition
10.2. TX-001HR: TherapeuticsMD
10.3. BHR-401 (Utrogestan): Besins Healthcare
10.4. Prasterone + Acolbifene: Endoceutics
10.5. MT-8554: Mitsubishi Tanabe Pharma
10.6. ESN364: Ogeda/ Astellas
10.7. NT-814: Nerre Therapeutics
10.8. Salubrin: Pherin Pharmaceuticals
10.9. Donesta: Mithra Pharmaceuticals (Donesta Biosciences)
10.10. FP-101: Fervent Pharmaceuticals
10.11. MLE4901 (AZD4901): Millendo Therapeutics
11. Hot Flashes 7 Major Market Analysis
12. The United States Market Outlook
13. EU-5 Countries: Market Outlook
13.1. Germany: Market Outlook
13.2. France: Market Outlook
13.3. Italy: Market Outlook
13.4. Spain: Market Outlook
13.5. United Kingdom: Market Outlook
13.6. Japan: Market Outlook
14. Market Drivers
15. Market Barriers
16. Appendix
17. DelveInsight Capabilities
18. Disclaimer
19. About DelveInsight
Related reports:
Hot Flashes Pipeline Insight, 2020
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/